FB Nasdaq FB Facebook

BAER Finishes Off Strong 2Q

Baer’s reported net income for the first half of CHF 114 million includes a significant amount of acquisition, integration, and one-off items. On an underlying basis, the bank’s net profit was CHF 261 million for the first half, up 26% from the year-ago half, as the bank benefited from higher assets under management and increased client activity. The bank’s underlying return on equity was about … Continue reading BAER Finishes Off Strong 2Q

Biotech Stock

Biotech Stocks in News: Major Biotech Stocks to Focus On

Here we have a close look at some of the major Biotech Stocks which have shown tremendous promise over the past few weeks. Investors are all recommended to closely monitor these stocks over the coming months as some movement is expected from these stocks. Portola Pharmaceuticals (PTLA), a biopharmaceutical company, develops product candidates in the fields of thrombosis and hematology. This stock closed up 4.1% … Continue reading Biotech Stocks in News: Major Biotech Stocks to Focus On

PBOC Announces Elimination of the Original Lending Rate Floor

The People’s Bank of China (PBOC) announced the elimination of the original lending rate floor of 30% discount to benchmark, allowing banks to lend at any discount to benchmark lending rates as they see fit. The PBOC scrapped the cap on lending rates in 2004, and this move will fully liberalize lending rates for banks. Greater pricing flexibility will enable the banks to retain their … Continue reading PBOC Announces Elimination of the Original Lending Rate Floor

PBCT Loan Segment Shows Growth

People’s United Financial reported net income of $62.1 million, or $0.20 per diluted share, in the second quarter of 2013 compared with $64.8 million, or $0.20 per diluted share, in the second quarter of 2012. Loans across all categories showed strong growth during the quarter, increasing at an annualized rate of 13%. The net interest margin declined to 3.33% for the second quarter compared with … Continue reading PBCT Loan Segment Shows Growth

Comparable Sales Look Good For Chipotle

Chipotle saw a nice sequential uptick in comparable restaurant sales during the second quarter, with much of the 5.5% increase stemming from ongoing peak-hour traffic throughput efforts as well as greater call-to-action marketing. Entering the quarter, there were concerns that competitive pressures (emergent fast-casual restaurant competition and more aggressive promotional activity from traditional quick-service and casual-dining players) might neutralize some of the throughput and marketing … Continue reading Comparable Sales Look Good For Chipotle

Biotech Stock Finance Bio Tech

Biotech Stock News: A Weekly Analysis of Major Biotech Stocks

Mergers and acquisitions were back in the news last week with Auxilium Pharmaceuticals (AUXL) being the target this time around. The company, which is looking to acquire QLT Inc (QLTI), received a proposal from Endo International plc (ENDP). Other updates last week include the usual regulatory and pipeline-related news. Gilead remained in the news thanks yet again to its hepatitis C virus (HCV) treatment, Sovaldi. … Continue reading Biotech Stock News: A Weekly Analysis of Major Biotech Stocks